Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results.
- Resource Type
- Article
- Source
- Stem Cells Translational Medicine; Oct2023, Vol. 12 Issue 10, p631-650, 20p
- Subject
- Language
- ISSN
- 21576564